peter attia tirzepatide How do Semaglutide and work, and why are they transforming diabetes and obesity care worldwide? Join our expert-led webinar to explore the science, clinical evidence, and real-world impact of these breakthrough Peter Attia Reveals 1 Supplement

What is co-formulation and why is it an advantage

Dual and triple receptor agonist development targeting GIP, GLP-1, and GCG receptors simultaneously is demonstrating superior weight loss and metabolic outcomes compared to single-receptor GLP-1 agents in clinical trials

JUST 3 CAPSULES PER DAY - Usable with all thyroid medications and with all thyroid conditions, all you need to do is take 3 capsules each day, in the morning, with or without food, for best results

In late 2024, Zealand Pharma initiated a phase 2b randomized dose-finding obesity and T2DM + obesity clinical trial (ZUPREME-1 and ZUPREME-2) which will evaluate petrelintides efficacy and safety in individuals with obesity in a larger population ( N = 480) [116]

The satiety effect of glucagon was blocked after disconnection of the hepatic branch of the abdominal vagus nerve [55]